Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplash
- Posted on June 11, 2026
- By Business News Today
- 0 Views
- 1 min read
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplash
Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic demand and positive global healthcare trends. Analysts see long-term growth potential from aging populations and innovation. Emerging opportunities from supply chain diversification away from China also present a positive outlook for Indian pharmaceutical companies.
